IMI (Inverness Medical Innovations) to acquire respiratory test maker Binax
This article was originally published in Clinica
Inverness Medical Innovations (IMI), the acquisitive maker of rapid diagnostic tests, has agreed to acquire Binax, a Portland, Maine company focused on respiratory infection testing. The deal, worth around $45m in cash and stock, is expected to close in spring 2005.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.